home / stock / brsyf / brsyf news

BRSYF News and Press, Brainsway Ltd Ord From 08/23/23

Stock Information
Company Name: Brainsway Ltd Ord
Stock Symbol: BRSYF
Market: OTC
Website: brainsway.com
Menu
BRSYF BRSYF Quote BRSYF Short BRSYF News BRSYF Articles BRSYF Message Board
Get BRSYF Alerts

News, Short Squeeze, Breakout and More Instantly...
BRSYF - BrainsWay Further Expands Access to Deep TMS(TM) in Asia Pacific Region

BURLINGTON, Mass. and JERUSALEM, Aug. 23, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the expanded ava...
BRSYF - BrainsWay: Profitability Is Within Sight

2023-08-10 16:07:33 ET Summary BrainsWay's Q2 results show continued revenue growth and improved cost control. The company is shifting its sales focus to larger institutions and enterprise customers, potentially improving sales efficiency. BrainsWay's market capitalization is ...

BRSYF - Brainsway Ltd (BWAY) Q2 2023 Earnings Call Transcript

2023-08-09 13:29:02 ET Brainsway Ltd (BWAY) Q2 2023 Earnings Conference Call August 09, 2023, 08:30 ET Company Participants Brian Ritchie - LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalma...

BRSYF - BrainsWay Reports Second Quarter 2023 Financial Results and Operational Highlights

BURLINGTON, Mass. and JERUSALEM, Aug. 09, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported second quarter 2023 financial results a...
BRSYF - BrainsWay Announces Publication of Three New Deep TMS Research Publications

BURLINGTON, Mass. and JERUSALEM, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced three recent pub...

BRSYF - BrainsWay to Report Second Quarter 2023 Financial Results on August 9, 2023

BURLINGTON, Mass. and JERUSALEM, July 26, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will rep...

BRSYF - BrainsWay Accelerates International Expansion in India

BURLINGTON, Mass. and JERUSALEM, July 11, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the expanded mar...
BRSYF - BrainsWay Announces Significant Expansion in Western and Central U.S.

BURLINGTON, Mass. and JERUSALEM, June 21, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced significant expa...

BRSYF - BrainsWay Q1 2023 Results: A Step In The Right Direction

2023-05-24 23:59:08 ET Summary BrainsWay has had a difficult 12 months, as a tough macro environment has overly impacted its customer base, which skews towards smaller companies. A return to growth and a renewed focus on profitability should begin moving BrainsWay towards breakeve...

BRSYF - BrainsWay Announces Appointment of Ido Marom as CFO

BURLINGTON, Mass. and JERUSALEM, May 23, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appointment o...
Previous 10 Next 10